Heron Slogan

My image

AirXpanders closes $10 M investment round and initiates U.S. Clinical study
January 23, 2012

AirXpanders Inc., a company developing innovative products addressing the breast and burn reconstruction markets, secured $10 million in Series D financing. Investors include Vivo Ventures, GBS Venture Partners, Heron Capital and Prolog Ventures.

This round will fund the ongoing U.S. Investigational Device Exemption (IDE) study for the AeroForm™ Patient Controlled Tissue Expander System.

Scott Dodson, CEO, said the company has already seen "great success" in the IDE study, with no adverse events reported to date.

Our Team

Heron Capital

9245 N. Meridian St., Ste. 101
Indianapolis, IN  46260

Phone: 317-686-1950
Fax: 317-686-1954

Susan Roederer
Fund Administrator and Executive Assistant









Download Marketing Sheet  
© Copyright 2019 Heron Capital